This website is no longer being updated. Please visit GBCHealth’s new website at:


RTI International


RTI International is one of the world’s leading research institutes, dedicated to improving the human condition by turning knowledge into practice. Our staff of more than 3,700 provides research and technical services to governments and businesses in more than 75 countries in the areas of health and pharmaceuticals, education and training, surveys and statistics, advanced technology, international development, economic and social policy, energy and the environment, and laboratory testing and chemical analysis.

Our global health experts focus on guiding effective policy formulation, improving the use of scarce financial resources, and strengthening health systems. Hallmarks of our work include development of successful public-private partnerships, integrated approaches to family health, and ground-breaking work in information and communication technology for health.

HIV/AIDS Profile

RTI brings together multidisciplinary teams to conduct innovative research and deliver effective and cost-efficient technical assistance-with a focus on HIV prevention and strengthening systems for service delivery. Our HIV/AIDS work builds upon behavioral research and interventions, including community based and clinical trials, in the U.S. and overseas, and decades of applied program experience in developing countries.

Tuberculosis Profile

RTI is a founding stakeholder in the Global Alliance for TB Drug Development and assists the National Institute of Allergy and Infectious Diseases (NIAID) with efforts to accelerate the commercial availability of new treatments for tuberculosis. RTI works to stimulate the involvement of pharmaceutical companies, and our work includes

  • Epidemiological analysis to assess global tuberculosis trends.
  • Business analysis to assess the market.
  • Technical analysis to document the potential of candidate compounds.
  • Promotion of those compounds to industry.
  • Management of development programs to advance promising drug candidates.

Malaria Profile

Since 1998, RTI has been partnering with U.S. and multilateral donors, host-country governments, and private-sector stakeholders to scale up the fight against malaria. We have worked in Africa, Asia, and Latin America to improve approaches to prevention, patient case management, and vector control, leveraging more than $350 million in funding to build sustainable platforms for country-led programs.

We have implemented numerous malaria projects under the U.S. President's Malaria Initiative (PMI), as well as private-sector clients. Our work has advanced best practices in country-level malaria program planning and budgeting, disease surveillance, environmental management and monitoring, and community-based diagnosis and treatment.